Selpercatinib will expand treatment options available for people with RET fusion positive non small cell lung cancer on the NHS in England.
Cancer Research UK presents charity collection in collaboration with influencer Shannon Alexandra at the Love Not Landfill fashion pop-up in London.
The targeted drug olaparib has been approved for some people with a type of advanced prostate cancer on the NHS in Scotland.
Patients taking the drug trastuzumab deruxecan were 72% less likely to see their cancer grow significantly or to die than those on an existing breast cancer treatment.
The new findings shed light on how cancer cells found in different parts of a tumour behave differently.
Around 8 in 10 pancreatic cancer cases are currently diagnosed late in England and Wales.
Using the technology, scientists have revealed that cell division isn’t necessarily the main cause of genetic changes in human tissue DNA.
Scientists are developing a new drug for treating acute myeloid leukaemia (AML), a type of blood cancer that affects around 3,100 people in the UK each year.
Reluctance to attend hospital tests and come forward about symptoms could be contributing to delays in lung cancer diagnosis.